OpenLB
Open Library of Bioscience
Advanced Search
Molecules (Basel, Switzerland)
Nov 30, 2022;27 (23):

Natural Products as Anticancer Agents: Current Status and Future Perspectives.

Abid Naeem, Pengyi Hu, Ming Yang, Jing Zhang, Yali Liu, Weifeng Zhu, Qin Zheng
Author Information
  1. Abid Naeem: Key Laboratory of Modern Preparation of Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
  2. Pengyi Hu: Key Laboratory of Modern Preparation of Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
  3. Ming Yang: Key Laboratory of Modern Preparation of Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
  4. Jing Zhang: Key Laboratory of Modern Preparation of Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
  5. Yali Liu: Key Laboratory of Pharmacodynamics and Safety Evaluation, Health Commission of Jiangxi Province, Nanchang Medical College, Nanchang 330006, China.
  6. Weifeng Zhu: Key Laboratory of Modern Preparation of Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
  7. Qin Zheng: Key Laboratory of Modern Preparation of Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
PMID: 36500466 DOI: 10.3390/molecules27238367

Abstract

Natural products have been an invaluable and useful source of anticancer agents over the years. Several compounds have been synthesized from natural products by modifying their structures or by using naturally occurring compounds as building blocks in the synthesis of these compounds for various purposes in different fields, such as biology, medicine, and engineering. Multiple modern and costly treatments have been applied to combat cancer and limit its lethality, but the results are not significantly refreshing. Natural products, which are a significant source of new therapeutic drugs, are currently being investigated as potential cytotoxic agents and have shown a positive trend in preclinical research and have prompted numerous innovative strategies in order to combat cancer and expedite the clinical research. Natural products are becoming increasingly important for drug discovery due to their high molecular diversity and novel biofunctionality. Furthermore, natural products can provide superior efficacy and safety due to their unique molecular properties. The objective of the current review is to provide an overview of the emergence of natural products for the treatment and prevention of cancer, such as chemosensitizers, immunotherapeutics, combinatorial therapies with other anticancer drugs, novel formulations of natural products, and the molecular mechanisms underlying their anticancer properties.

Keywords

anti-cancer plants bioactive anti-tumor agents chemoprevention chemotherapy natural products phytochemicals

References

Cell Death Dis. 2014 Oct 16;5:e1465 [PMID: 25321472]
Int J Biol Sci. 2018 Feb 9;14(2):217-227 [PMID: 29483839]
Drug Discov Today. 2016 Feb;21(2):204-7 [PMID: 25617672]
Evol Appl. 2009 Feb;2(1):62-70 [PMID: 25567847]
Fitoterapia. 2020 Jun;143:104552 [PMID: 32173422]
Oncol Rep. 2018 Oct;40(4):2127-2136 [PMID: 30106443]
IUBMB Life. 2012 Sep;64(9):783-94 [PMID: 22837216]
In Vitro Cell Dev Biol Anim. 2018 Oct;54(9):629-639 [PMID: 30136034]
J Food Drug Anal. 2019 Oct;27(4):887-896 [PMID: 31590760]
Asian Pac J Cancer Prev. 2014;15(8):3575-9 [PMID: 24870760]
Cell Death Dis. 2018 Aug 29;9(9):875 [PMID: 30158521]
Eur J Pharmacol. 2016 Mar 5;774:105-17 [PMID: 26849940]
Hepatogastroenterology. 2012 Jun;59(116):1251-7 [PMID: 22440189]
Cell Mol Immunol. 2004 Feb;1(1):63-70 [PMID: 16212923]
Food Funct. 2019 Jul 17;10(7):4361-4371 [PMID: 31276149]
Adv Drug Deliv Rev. 2022 Sep;188:114445 [PMID: 35820601]
J Agric Food Chem. 2018 Jan 24;66(3):602-612 [PMID: 29276946]
J Exp Clin Cancer Res. 2017 Dec 22;36(1):190 [PMID: 29273065]
Biomaterials. 2020 May;241:119907 [PMID: 32120315]
Cell Death Dis. 2019 Jul 15;10(8):540 [PMID: 31308358]
JAMA. 2017 Aug 8;318(6):572-574 [PMID: 28787497]
J Nat Prod. 2016 Mar 25;79(3):629-61 [PMID: 26852623]
Molecules. 2016 Nov 24;21(12): [PMID: 27886147]
J Agric Food Chem. 2020 Jan 8;68(1):213-224 [PMID: 31861958]
Toxicology. 2011 Nov 18;289(2-3):91-102 [PMID: 21843585]
J Transl Med. 2016 Feb 08;14:42 [PMID: 26856330]
Sci China Life Sci. 2019 May;62(5):640-647 [PMID: 30900169]
Cancer Med. 2019 Aug;8(10):4806-4820 [PMID: 31273958]
Br J Pharmacol. 2020 Mar;177(6):1409-1423 [PMID: 31368509]
Food Chem Toxicol. 2013 May;55:214-21 [PMID: 23274058]
Gan To Kagaku Ryoho. 2015 Jan;42(1):101-4 [PMID: 25596689]
Pharmacogn Mag. 2018 Apr-Jun;14(54):207-213 [PMID: 29720833]
Oncol Rep. 2014 Apr;31(4):1788-94 [PMID: 24573532]
Cell Biol Int. 2013 Oct;37(10):1046-54 [PMID: 23686743]
Nutrients. 2019 Jun 29;11(7): [PMID: 31261861]
Mol Carcinog. 2010 Jul;49(7):630-40 [PMID: 20564340]
Pharmacology. 2008;82(2):148-55 [PMID: 18667841]
Front Oncol. 2021 Apr 12;11:660712 [PMID: 33912467]
Cancer Lett. 2019 Jul 1;453:57-73 [PMID: 30930233]
Oncotarget. 2018 Apr 24;9(31):22194-22219 [PMID: 29774132]
Mol Med Rep. 2016 Nov;14(5):4349-4359 [PMID: 27667394]
World J Oncol. 2019 Apr;10(2):63-89 [PMID: 31068988]
Sci Rep. 2017 Nov 9;7(1):15174 [PMID: 29123181]
Zhongguo Zhong Yao Za Zhi. 2018 Dec;43(23):4665-4671 [PMID: 30717556]
Life Sci. 2020 Sep 1;256:118000 [PMID: 32585246]
J Nat Prod. 2020 Mar 27;83(3):770-803 [PMID: 32162523]
Crit Rev Immunol. 2011;31(4):265-95 [PMID: 21899511]
Food Chem Toxicol. 2011 Jul;49(7):1616-25 [PMID: 21515332]
Future Oncol. 2019 Apr;15(11):1243-1253 [PMID: 30843426]
Drug Discov Today. 2022 Jul;27(7):1936-1944 [PMID: 35182736]
Mol Nutr Food Res. 2010 Jul;54(7):918-28 [PMID: 20077420]
Onco Targets Ther. 2016 Feb 04;9:635-41 [PMID: 26893573]
Oncol Res. 2018 Sep 14;26(8):1207-1213 [PMID: 28899457]
Oncol Rep. 2017 Oct;38(4):2525-2534 [PMID: 28849227]
Drug Deliv. 2017 Nov;24(1):1791-1800 [PMID: 29172759]
Biochem Biophys Res Commun. 2014 Jul 18;450(1):247-54 [PMID: 24887566]
Mol Carcinog. 2013 Aug;52(8):591-602 [PMID: 22407812]
J Med Food. 2012 Apr;15(4):344-9 [PMID: 22191568]
Onco Targets Ther. 2015 Jan 30;8:303-11 [PMID: 25674005]
J Cell Physiol. 2019 Feb 25;: [PMID: 30805937]
Clin Exp Pharmacol Physiol. 2008 Sep;35(9):995-1001 [PMID: 18430063]
Pharmaceutics. 2020 May 28;12(6): [PMID: 32481565]
Front Pharmacol. 2018 Feb 05;9:68 [PMID: 29459827]
Planta Med. 2003 Jan;69(1):21-5 [PMID: 12567274]
PLoS One. 2013 Aug 01;8(8):e70372 [PMID: 23936419]
J Nutr Biochem. 2019 Jan;63:62-71 [PMID: 30342318]
Mol Biol Cell. 2014 Sep 15;25(18):2677-81 [PMID: 25213191]
Biomaterials. 2016 Sep;100:27-40 [PMID: 27240160]
Cancer Lett. 2013 Aug 19;336(2):281-9 [PMID: 23523616]
BMC Complement Altern Med. 2016 Feb 27;16:86 [PMID: 26922065]
Cancer Lett. 2020 Jun 1;479:61-70 [PMID: 32014461]
Biochem Biophys Res Commun. 2013 Jan 11;430(2):846-51 [PMID: 23200838]
Biomed Pharmacother. 2020 May;125:110009 [PMID: 32106381]
Phytother Res. 2018 Dec;32(12):2456-2465 [PMID: 30251417]
Molecules. 2018 Feb 26;23(3): [PMID: 29495398]
Am J Chin Med. 2019;47(3):635-656 [PMID: 31023073]
Oncol Rep. 2014 May;31(5):2131-8 [PMID: 24627125]
Biomed Pharmacother. 2020 Jan;121:109570 [PMID: 31710893]
Evid Based Complement Alternat Med. 2015;2015:921306 [PMID: 25949267]
Viruses. 2021 May 28;13(6): [PMID: 34071559]
Oncol Lett. 2015 Oct;10(4):2359-2365 [PMID: 26622852]
Toxicol Appl Pharmacol. 2017 Oct 1;332:32-39 [PMID: 28754437]
Molecules. 2011 Sep 30;16(10):8343-52 [PMID: 21963624]
J Hematol Oncol. 2013 Mar 16;6:21 [PMID: 23497456]
J Nat Med. 2012 Jan;66(1):62-9 [PMID: 21879332]
Oncol Lett. 2015 Jul;10(1):168-174 [PMID: 26170994]
Oncotarget. 2019 Feb 1;10(10):1085-1101 [PMID: 30800220]
Toxicol In Vitro. 2010 Sep;24(6):1546-53 [PMID: 20615460]
Life Sci. 2018 Jun 1;202:188-194 [PMID: 29625193]
Evid Based Complement Alternat Med. 2020 Jan 3;2020:8747023 [PMID: 32015754]
Drug Des Devel Ther. 2020 Feb 18;14:647-659 [PMID: 32109990]
Molecules. 2022 Jul 27;27(15): [PMID: 35956766]
Cancer Lett. 2017 Mar 28;389:70-77 [PMID: 27998762]
Nat Rev Clin Oncol. 2019 Nov;16(11):669-683 [PMID: 31189965]
Toxicol Lett. 2013 Jul 4;220(2):157-66 [PMID: 23660334]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Jun;32(6):770-4 [PMID: 27371844]
Oncol Res. 2019 May 7;27(5):593-600 [PMID: 28911340]
Am J Chin Med. 2017;45(2):337-350 [PMID: 28231748]
Front Pharmacol. 2017 Sep 12;8:640 [PMID: 28955240]
Fitoterapia. 2010 Oct;81(7):830-3 [PMID: 20472039]
Eur J Pharmacol. 2013 Oct 15;718(1-3):1-9 [PMID: 24051269]
Cancer Lett. 2008 Aug 18;267(1):85-95 [PMID: 18430509]
Mol Carcinog. 2017 Jan;56(1):75-93 [PMID: 26878598]
Mol Med Rep. 2013 Oct;8(4):1279-85 [PMID: 23969579]
EMBO Mol Med. 2017 Jan;9(1):4-6 [PMID: 27852619]
Int J Oncol. 2017 Apr;50(4):1341-1351 [PMID: 28259926]
Anticancer Drugs. 2006 Aug;17(7):839-48 [PMID: 16926633]
Sci Rep. 2019 Apr 23;9(1):6428 [PMID: 31015523]
Phytother Res. 2015 May;29(5):680-6 [PMID: 25625870]
Chem Biol Interact. 2014 Jul 25;218:1-9 [PMID: 24792648]
Int J Mol Sci. 2020 May 16;21(10): [PMID: 32429376]
J Cancer Res Ther. 2016 Oct-Dec;12(4):1266-1271 [PMID: 28169238]
J Agric Food Chem. 2011 Dec 28;59(24):13328-36 [PMID: 22087557]
ACS Appl Mater Interfaces. 2018 Mar 28;10(12):9938-9948 [PMID: 29436217]
Tumour Biol. 2016 May;37(5):6987-96 [PMID: 26662956]
J Ethnopharmacol. 2016 Dec 24;194:1-5 [PMID: 27566201]
J Med Chem. 2012 Jul 12;55(13):5989-6001 [PMID: 22537178]
Pharmaceutics. 2018 Nov 15;10(4): [PMID: 30445705]
J Ethnopharmacol. 2017 May 5;203:27-38 [PMID: 28341244]
PLoS One. 2015 Sep 17;10(9):e0138710 [PMID: 26379052]
Prostate Cancer Prostatic Dis. 2019 Sep;22(3):351-361 [PMID: 30651580]
Biochem Pharmacol. 2020 Oct;180:114167 [PMID: 32702370]
Oncogene. 2002 Oct 24;21(49):7533-44 [PMID: 12386816]
Mater Sci Eng C Mater Biol Appl. 2019 May;98:685-695 [PMID: 30813073]
J Exp Clin Cancer Res. 2018 Jan 15;37(1):7 [PMID: 29334999]
Chem Biol Interact. 2017 Aug 25;274:100-106 [PMID: 28709945]
Mater Sci Eng C Mater Biol Appl. 2016 Jul 1;64:124-132 [PMID: 27127036]
Int Immunopharmacol. 2013 Jun;16(2):332-40 [PMID: 23639256]
J Physiol Biochem. 2017 May;73(2):157-165 [PMID: 27834040]
Biofactors. 2016 Sep 10;42(5):475-491 [PMID: 27219221]
PLoS One. 2011 Apr 12;6(4):e18308 [PMID: 21532751]
CA Cancer J Clin. 2021 May;71(3):209-249 [PMID: 33538338]
Int Immunopharmacol. 2011 Jul;11(7):890-8 [PMID: 21244860]
Oncogene. 2001 May 24;20(23):2927-36 [PMID: 11420705]
J Cancer. 2015 May 23;6(7):623-31 [PMID: 26078792]
Food Chem Toxicol. 2019 May;127:53-60 [PMID: 30851366]
Oxid Med Cell Longev. 2021 Oct 18;2021:3687700 [PMID: 34707776]
PLoS One. 2015 Jun 22;10(6):e0130685 [PMID: 26098839]
Mar Drugs. 2017 Feb 15;15(2): [PMID: 28212270]
J Neurosurg. 2017 May;126(5):1448-1460 [PMID: 27419830]
Cells. 2019 Jul 30;8(8): [PMID: 31366086]
Oncol Lett. 2017 Oct;14(4):4243-4248 [PMID: 28943934]
J Nat Prod. 2018 Mar 23;81(3):625-629 [PMID: 29406734]
J Oral Pathol Med. 2018 Aug;47(7):674-682 [PMID: 29777637]
Hematology. 2004 Feb;9(1):41-5 [PMID: 14965867]
J Natl Cancer Inst. 2022 Mar 8;114(3):353-360 [PMID: 34743211]
Arch Biochem Biophys. 2020 May 15;684:108314 [PMID: 32088220]
Nutr Cancer. 2022;74(3):779-795 [PMID: 34100309]
Biomed Pharmacother. 2018 Dec;108:130-136 [PMID: 30218857]
Evid Based Complement Alternat Med. 2016;2016:5352412 [PMID: 27478478]
Am J Chin Med. 2011;39(4):803-15 [PMID: 21721158]
J Cancer. 2017 Sep 20;8(17):3416-3429 [PMID: 29151925]
PLoS One. 2014 Feb 14;9(2):e87286 [PMID: 24551054]
Cell Death Dis. 2019 Dec 9;10(12):936 [PMID: 31819048]
Anticancer Res. 2019 Jan;39(1):57-66 [PMID: 30591440]
J Cancer Res Ther. 2016 Jan-Mar;12(1):155-60 [PMID: 27072230]
Cancer Manag Res. 2019 Oct 15;11:8923-8936 [PMID: 31686915]
J Control Release. 2021 Jul 10;335:1-20 [PMID: 33991600]
Cytotechnology. 2010 Dec;62(6):573-83 [PMID: 20963488]
Int J Mol Med. 2018 Jun;41(6):3485-3492 [PMID: 29512690]
Int J Nanomedicine. 2019 Jan 11;14:499-517 [PMID: 30666110]
Curr Pharm Des. 2020;26(4):455-465 [PMID: 31969092]
Biochem Biophys Res Commun. 2008 Jul 18;372(1):236-42 [PMID: 18485277]
J Biomed Res. 2015 Apr;29(2):132-8 [PMID: 25859268]
Cells. 2022 Jul 15;11(14): [PMID: 35883653]
Phytomedicine. 2018 Dec 1;51:214-225 [PMID: 30466620]
Oncol Rep. 2018 Sep;40(3):1525-1532 [PMID: 30015938]
Int J Mol Med. 2013 Nov;32(5):1077-84 [PMID: 24048272]
Cancer Lett. 2008 Oct 8;269(2):226-42 [PMID: 18492603]
J Nat Prod. 2016 Oct 28;79(10):2464-2471 [PMID: 27726390]
Exp Mol Med. 2012 Nov 30;44(11):633-41 [PMID: 22902510]
Chem Biol Interact. 2015 Dec 5;242:25-33 [PMID: 26332055]
Crit Rev Food Sci Nutr. 2022;62(26):7222-7241 [PMID: 33890518]
J Ethnopharmacol. 2009 Jun 22;123(2):293-301 [PMID: 19429375]
Oxid Med Cell Longev. 2019 Mar 7;2019:4619865 [PMID: 30984336]
Chin Med J (Engl). 2012 Mar;125(5):786-93 [PMID: 22490576]
Oncol Rep. 2015 Jun;33(6):2829-36 [PMID: 25845681]
Sci Rep. 2020 Jul 15;10(1):11681 [PMID: 32669593]
J Natl Cancer Inst. 1981 Jun;66(6):1191-308 [PMID: 7017215]
Nat Rev Clin Oncol. 2010 Dec;7(12):669-70 [PMID: 21116236]
J Agric Food Chem. 2019 Jul 3;67(26):7378-7389 [PMID: 31184118]
Carcinogenesis. 2012 Dec;33(12):2488-98 [PMID: 23027625]
Biochem Pharmacol. 2004 Aug 1;68(3):441-52 [PMID: 15242811]
J Cancer Res Clin Oncol. 2019 May;145(5):1087-1109 [PMID: 30903319]
Nutrients. 2016 Mar 10;8(3):156 [PMID: 26978396]
Cell Death Dis. 2019 May 28;10(6):415 [PMID: 31138779]
Horm Metab Res. 2014 Oct;46(11):753-60 [PMID: 24977660]
Front Oncol. 2020 Jan 17;9:1469 [PMID: 32010609]
Cancer Sci. 2017 Apr;108(4):574-580 [PMID: 28188673]
Food Chem Toxicol. 2019 Mar;125:566-582 [PMID: 30685472]
Cell Death Dis. 2013 Sep 19;4:e804 [PMID: 24052072]
Molecules. 2019 Sep 05;24(18): [PMID: 31492037]
Cancer Cell Int. 2019 Mar 08;19:54 [PMID: 30899201]
Mol Cancer. 2013 Aug 30;12(1):99 [PMID: 24001151]
Acta Pharm Sin B. 2022 Nov;12(11):4011-4039 [PMID: 36386472]
Sci Rep. 2017 Mar 23;7:44990 [PMID: 28332554]
Sci Rep. 2016 Sep 13;6:32979 [PMID: 27622714]
Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S91-100 [PMID: 20374035]
Int J Mol Med. 2014 Jun;33(6):1613-20 [PMID: 24682388]
Cancer Prev Res (Phila). 2016 Jul;9(7):607-15 [PMID: 27138790]
Cancer Res. 2007 Feb 1;67(3):1130-7 [PMID: 17283147]
Life Sci. 2018 Apr 15;199:48-59 [PMID: 29510199]
Ai Zheng. 2005 Dec;24(12):1464-8 [PMID: 16351793]
Clin Cancer Res. 2018 Jan 1;24(1):130-144 [PMID: 28951519]
Oncol Lett. 2015 Oct;10(4):2627-2633 [PMID: 26622901]
Biomedicines. 2020 Aug 20;8(9): [PMID: 32825464]
Chin J Integr Med. 2017 Jun;23(6):453-460 [PMID: 27796822]
Phytother Res. 2019 Jun;33(6):1689-1696 [PMID: 30932278]
Mol Cancer Ther. 2009 Jun;8(6):1613-24 [PMID: 19509257]
Oncotarget. 2016 Aug 30;7(35):56767-56780 [PMID: 27462923]
Nutr Cancer. 2020;72(6):1043-1056 [PMID: 31544515]
Cell Prolif. 2018 Dec;51(6):e12518 [PMID: 30152053]
Oncol Rep. 2020 Mar;43(3):807-816 [PMID: 32020219]
Nat Prod Bioprospect. 2015 Mar 29;: [PMID: 25821199]
Int J Mol Sci. 2013 Mar 15;14(3):6012-25 [PMID: 23502466]
Int J Pharm. 2017 Aug 7;528(1-2):88-99 [PMID: 28533175]
Med Sci Monit. 2019 Nov 12;25:8534-8543 [PMID: 31714902]
Mol Carcinog. 2010 Feb;49(2):141-51 [PMID: 19777565]
Semin Cancer Biol. 2016 Oct;40-41:1-3 [PMID: 27565447]
Carcinogenesis. 2016 Sep;37(9):918-928 [PMID: 27335141]
Med Sci Monit. 2019 Aug 12;25:6015-6022 [PMID: 31404056]
Tumour Biol. 2016 Sep;37(9):12455-12464 [PMID: 27333990]
Oncotarget. 2015 Oct 20;6(32):32790-804 [PMID: 26447544]
J Biochem Mol Toxicol. 2018 Oct;32(10):e22206 [PMID: 30091159]
Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3343-3351 [PMID: 29286229]
Neurochem Res. 2016 Jun;41(6):1439-47 [PMID: 26846141]
Toxicol Appl Pharmacol. 2017 Jul 1;326:25-33 [PMID: 28416456]
Mol Med Rep. 2014 Aug;10(2):1046-50 [PMID: 24889088]
Cell Biol Int. 2017 Dec;41(12):1367-1378 [PMID: 28880428]
J Ginseng Res. 2015 Apr;39(2):125-34 [PMID: 26045685]
Microvasc Res. 2016 Sep;107:17-33 [PMID: 27133199]
Mol Pharmacol. 2012 Dec;82(6):1115-28 [PMID: 22956772]
Semin Immunol. 2017 Jun;31:37-54 [PMID: 28838796]
Biomed Pharmacother. 2017 Nov;95:68-76 [PMID: 28826099]
Biochem Biophys Res Commun. 2019 Jun 25;514(2):510-517 [PMID: 31056260]
Mol Biol Rep. 2019 Apr;46(2):2085-2092 [PMID: 30719606]
Cancer Cell Int. 2017 Mar 7;17:38 [PMID: 28286420]
Mar Drugs. 2018 Oct 14;16(10): [PMID: 30322180]
Haematologica. 2020 Jan;105(1):148-160 [PMID: 30975912]
Eur J Pharmacol. 2018 Feb 15;821:1-10 [PMID: 29247613]
Anticancer Agents Med Chem. 2018;18(2):216-236 [PMID: 28745237]
J Cancer. 2019 Jun 2;10(13):2849-2856 [PMID: 31281461]
Biomed Pharmacother. 2017 Nov;95:1388-1396 [PMID: 28946186]
Oncol Rep. 2012 Feb;27(2):567-72 [PMID: 22020372]
Phytochemistry. 2015 Jan;109:96-102 [PMID: 25468714]
J Androl. 2009 Mar-Apr;30(2):122-6 [PMID: 18974423]
Pharmacol Res. 2020 Sep;159:104934 [PMID: 32464330]
Planta Med. 2015 Jan;81(1):32-8 [PMID: 25473921]
Mol Med Rep. 2018 Dec;18(6):5572-5578 [PMID: 30365080]
Biosci Biotechnol Biochem. 2012;76(7):1322-8 [PMID: 22785466]
Theranostics. 2016 Apr 12;6(6):875-86 [PMID: 27162557]
Cancer Sci. 2011 Jan;102(1):219-25 [PMID: 21087351]
Saudi Pharm J. 2017 May;25(4):638-643 [PMID: 28579904]
Recent Pat Anticancer Drug Discov. 2016;11(1):67-97 [PMID: 26537958]
Mol Med Rep. 2015 Jun;11(6):4617-24 [PMID: 25634350]
Oncol Lett. 2018 Oct;16(4):5020-5026 [PMID: 30250568]
Oncotarget. 2016 Aug 9;7(32):52517-52529 [PMID: 27232756]
Biochem Biophys Res Commun. 2016 Feb 26;471(1):63-7 [PMID: 26845352]
Int J Biochem Cell Biol. 2017 Mar;84:58-74 [PMID: 28093328]
PLoS One. 2017 Dec 27;12(12):e0189864 [PMID: 29281678]
Oncol Lett. 2016 Jan;11(1):267-272 [PMID: 26870201]
Oncol Rep. 2017 Sep;38(3):1373-1382 [PMID: 28731173]
Biomed Pharmacother. 2017 Dec;96:1299-1309 [PMID: 29174033]
Phytomedicine. 2017 May 15;28:10-18 [PMID: 28478808]
Nat Prod Res. 2019 Jun;33(12):1828-1831 [PMID: 29447469]
Exp Mol Pathol. 2020 Feb;112:104349 [PMID: 31778668]
Biochem Pharmacol. 2010 Jul 15;80(2):247-54 [PMID: 20346922]
Biomed Res Int. 2018 Jan 31;2018:4010629 [PMID: 29651429]
Biomed Pharmacother. 2019 Jan;109:2365-2374 [PMID: 30551496]
Cancer Biol Ther. 2016 Sep;17(9):966-75 [PMID: 27434731]
Cell Biochem Biophys. 2015 May;72(1):203-13 [PMID: 25510462]
Biomed Pharmacother. 2019 Apr;112:108592 [PMID: 30784907]
Eur J Pharmacol. 2012 Aug 5;688(1-3):14-21 [PMID: 22617025]
J Cell Mol Med. 2020 Jul;24(13):7427-7438 [PMID: 32558259]
Biochem Biophys Res Commun. 2017 Feb 26;484(1):85-92 [PMID: 28104392]
Oncotarget. 2016 Mar 22;7(12):14616-27 [PMID: 26910280]
Oncol Lett. 2013 May;5(5):1605-1610 [PMID: 23761826]
Int J Nanomedicine. 2020 Mar 31;15:2259-2268 [PMID: 32280218]
PLoS One. 2013 Jun 21;8(6):e66598 [PMID: 23805245]
Int Braz J Urol. 2009 May-Jun;35(3):354-60; discussion 361 [PMID: 19538771]
J Exp Clin Cancer Res. 2017 Aug 10;36(1):107 [PMID: 28797284]
Oncotarget. 2016 Jan 26;7(4):3819-31 [PMID: 26683363]
Adv Exp Med Biol. 2010;678:157-64 [PMID: 20738018]
Oncoimmunology. 2012 Oct 1;1(7):1111-1134 [PMID: 23170259]
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3500-3510 [PMID: 31432697]
J Cell Biochem. 2017 Sep;118(9):2865-2876 [PMID: 28214344]
Afr J Tradit Complement Altern Med. 2011;8(2):177-84 [PMID: 22238500]
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2363-2369 [PMID: 29966656]
Front Pharmacol. 2022 Sep 08;13:950109 [PMID: 36160435]
IUBMB Life. 2019 Oct;71(10):1595-1610 [PMID: 31251469]
Curr Cancer Drug Targets. 2018;18(3):239-255 [PMID: 28359240]
Int J Mol Sci. 2020 Feb 07;21(3): [PMID: 32046099]
Toxicol In Vitro. 2011 Aug;25(5):1027-32 [PMID: 21466843]
Iran J Basic Med Sci. 2019 Aug;22(8):833-847 [PMID: 31579438]
Fitoterapia. 2019 Mar;133:175-179 [PMID: 30660654]
PLoS One. 2013 Sep 09;8(9):e72882 [PMID: 24039814]
Compr Rev Food Sci Food Saf. 2018 Mar;17(2):472-495 [PMID: 33350084]
Biochem Pharmacol. 2011 Sep 1;82(5):453-63 [PMID: 21669190]
Acta Biochim Biophys Sin (Shanghai). 2018 Jun 1;50(6):532-539 [PMID: 29701777]
Int J Immunopathol Pharmacol. 2017 Dec;30(4):353-361 [PMID: 28994628]
Oncotarget. 2018 Apr 6;9(26):18115-18127 [PMID: 29719594]
FEMS Immunol Med Microbiol. 2011 Nov;63(2):228-35 [PMID: 22077226]
Cell Mol Neurobiol. 2013 Oct;33(7):921-8 [PMID: 23842993]
Int Immunopharmacol. 2015 Feb;24(2):423-431 [PMID: 25596038]
Onco Targets Ther. 2020 Jul 29;13:7447-7458 [PMID: 32801767]
Int J Mol Sci. 2018 Feb 02;19(2): [PMID: 29393891]
Oncol Rep. 2011 Nov;26(5):1149-56 [PMID: 21785828]
Am J Transl Res. 2016 Jul 15;8(7):3299-308 [PMID: 27508051]
Oncol Rep. 2015 Dec;34(6):2845-52 [PMID: 26397053]
Oncotarget. 2018 Jan 8;9(28):20089-20102 [PMID: 29732005]
Tumour Biol. 2014 Dec;35(12):11985-94 [PMID: 25168366]
Biochem Pharmacol. 2002 Feb 15;63(4):707-15 [PMID: 11992639]
J Pharm Pharmacol. 2008 Feb;60(2):139-44 [PMID: 18237460]
Biol Pharm Bull. 2019 Oct 1;42(10):1720-1725 [PMID: 31378747]
Biomed Pharmacother. 2017 Aug;92:661-671 [PMID: 28586740]
Fitoterapia. 2019 Apr;134:172-181 [PMID: 30825580]
Br J Pharmacol. 1999 Sep;128(2):345-56 [PMID: 10510444]
Oncol Rep. 2013 Aug;30(2):685-94 [PMID: 23708383]
Int J Oncol. 2014 Aug;45(2):683-90 [PMID: 24888720]
Genet Mol Biol. 2013 Mar;36(1):105-10 [PMID: 23569415]
Molecules. 2017 Feb 07;22(2): [PMID: 28178219]
Onco Targets Ther. 2018 Apr 04;11:1833-1847 [PMID: 29670359]
Mol Pharm. 2020 Jul 6;17(7):2411-2425 [PMID: 32437163]
Phytother Res. 2019 May;33(5):1570-1578 [PMID: 30907037]
Apoptosis. 2011 Apr;16(4):394-403 [PMID: 21259053]
Environ Toxicol. 2018 Sep;33(9):913-922 [PMID: 29962003]
Balkan Med J. 2019 Oct 09;37(1):29-33 [PMID: 31594288]
Nat Prod Res. 2017 Sep;31(17):2032-2041 [PMID: 28105861]
BMC Complement Altern Med. 2015 Oct 30;15:393 [PMID: 26518729]
Molecules. 2016 Dec 21;21(12): [PMID: 28009843]
Sci Rep. 2016 Feb 19;6:21148 [PMID: 26892186]
Eur J Pharmacol. 2019 Jun 5;852:231-243 [PMID: 30959046]
Phytomedicine. 2010 Sep;17(11):856-61 [PMID: 20362422]
Toxicol Lett. 2014 Feb 10;225(1):66-77 [PMID: 24300171]
Int J Mol Sci. 2019 May 09;20(9): [PMID: 31075954]
J Agric Food Chem. 2016 May 18;64(19):3804-9 [PMID: 27115720]
Med Sci Monit. 2018 Oct 07;24:7146-7151 [PMID: 30293083]
Pharmacol Rep. 2015 Apr;67(2):245-52 [PMID: 25712646]
Oncotarget. 2016 Feb 16;7(7):8090-104 [PMID: 26811496]
Cancer Lett. 2015 Feb 1;357(1):219-230 [PMID: 25444914]
J BUON. 2020 Mar-Apr;25(2):1166-1171 [PMID: 32521922]
Biol Pharm Bull. 2018 Aug 1;41(8):1194-1202 [PMID: 29848900]
J Cell Physiol. 2010 Oct;225(1):266-75 [PMID: 20509140]
Bioorg Med Chem Lett. 2017 Feb 15;27(4):893-896 [PMID: 28119023]
Mar Drugs. 2017 Jul 15;15(7): [PMID: 28714874]
Oncol Rep. 2020 Jan;43(1):282-295 [PMID: 31789425]
Mol Carcinog. 2019 Jul;58(7):1248-1259 [PMID: 31100197]
Int J Oncol. 2017 Feb;50(2):684-696 [PMID: 28101577]
Acta Pharmacol Sin. 2011 Mar;32(3):345-53 [PMID: 21372826]
Biomolecules. 2019 Sep 16;9(9): [PMID: 31527550]
Biochem Biophys Res Commun. 2009 Aug 14;386(1):140-5 [PMID: 19501048]
Cancer Res. 2010 Apr 15;70(8):3259-68 [PMID: 20354190]
CA Cancer J Clin. 2018 Nov;68(6):394-424 [PMID: 30207593]
J Ethnopharmacol. 2016 Dec 24;194:1043-1050 [PMID: 27833027]
Drug Des Devel Ther. 2017 Aug 23;11:2481-2491 [PMID: 28860718]
Semin Cancer Biol. 2022 May;80:306-339 [PMID: 32610149]
Cancer Lett. 2010 Aug 1;294(1):118-24 [PMID: 20153103]
J Sci Food Agric. 2012 Mar 15;92(4):965-74 [PMID: 22012678]
Food Chem Toxicol. 2020 Sep;143:111570 [PMID: 32640345]
Biol Pharm Bull. 2019;42(9):1500-1509 [PMID: 31474710]
Front Pharmacol. 2015 Nov 09;6:267 [PMID: 26617519]
J Agric Food Chem. 2017 Sep 13;65(36):7893-7899 [PMID: 28763204]
Int J Mol Med. 2012 Apr;29(4):607-12 [PMID: 22246103]
Mol Med Rep. 2017 Oct;16(4):3894-3900 [PMID: 28731159]
Int J Mol Sci. 2016 Nov 18;17(11): [PMID: 27869737]
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):84-95 [PMID: 31852250]
Environ Toxicol. 2019 Oct;34(10):1085-1093 [PMID: 31184425]
Eur J Pharmacol. 2005 Nov 21;525(1-3):32-40 [PMID: 16289142]
Biochem Biophys Res Commun. 2015 May 1;460(2):136-42 [PMID: 25747710]
Med Sci Monit. 2019 Oct 20;25:7853-7863 [PMID: 31630150]
Basic Clin Pharmacol Toxicol. 2014 Dec;115(6):507-11 [PMID: 24842412]
Med Sci Monit. 2019 Jan 25;25:739-745 [PMID: 30681987]
Med Sci Monit. 2016 Dec 14;22:4911-4917 [PMID: 27966519]
Oncotarget. 2015 Jun 20;6(17):15348-61 [PMID: 25915156]
Cancer Lett. 2016 May 28;375(1):114-126 [PMID: 26963494]
Cancer Sci. 2019 Jan;110(1):334-344 [PMID: 30353606]
Nutr Cancer. 2013;65(8):1208-18 [PMID: 24099079]
J Clin Biochem Nutr. 2016 Jan;58(1):40-7 [PMID: 26798196]
J Ethnopharmacol. 2017 Jun 9;205:33-40 [PMID: 28456578]
J Food Drug Anal. 2020 Jan;28(1):14-37 [PMID: 31883602]
PLoS One. 2015 Mar 31;10(3):e0122374 [PMID: 25825910]
Oncol Lett. 2019 Feb;17(2):1877-1882 [PMID: 30675250]
Biochem Biophys Res Commun. 2011 Nov 18;415(2):325-9 [PMID: 22033405]
Toxicol Lett. 2013 Oct 24;222(2):91-101 [PMID: 23933019]
Int Immunopharmacol. 2012 Sep;14(1):99-106 [PMID: 22749847]
J Agric Food Chem. 2015 Oct 21;63(41):9047-52 [PMID: 26442822]
Semin Cancer Biol. 2021 Feb;69:5-23 [PMID: 31421264]
Nat Rev Drug Discov. 2021 Mar;20(3):200-216 [PMID: 33510482]
Curr Pharmacol Rep. 2015 Feb 1;1(1):46-51 [PMID: 25774338]
Life Sci. 2013 Sep 3;93(8):323-8 [PMID: 23871804]
Phytomedicine. 2016 Jun 15;23(7):725-35 [PMID: 27235711]
Onco Targets Ther. 2018 Apr 09;11:2017-2028 [PMID: 29670377]
Cell Immunol. 2017 Jan;311:86-93 [PMID: 27825563]
Pharmacol Res. 2017 Jan;115:288-298 [PMID: 27940017]
Neurol Clin. 2016 Nov;34(4):981-998 [PMID: 27720005]
Biol Pharm Bull. 2018 Jan 1;41(1):36-46 [PMID: 29093327]
Heliyon. 2019 May 09;5(5):e01675 [PMID: 31193061]
EPMA J. 2021 May 17;12(2):155-176 [PMID: 34025826]
Invest New Drugs. 2012 Apr;30(2):548-57 [PMID: 21120579]
Oncol Lett. 2018 Apr;15(4):5473-5480 [PMID: 29552188]
Cell Physiol Biochem. 2017;41(1):339-357 [PMID: 28214826]
Nihon Yakurigaku Zasshi. 2019;153(4):147-154 [PMID: 30971653]
Sci Rep. 2016 Oct 12;6:35263 [PMID: 27731376]
Int J Biochem Cell Biol. 2016 May;74:95-108 [PMID: 26939786]
Biomolecules. 2020 May 04;10(5): [PMID: 32375296]
Anticancer Agents Med Chem. 2018;18(9):1313-1322 [PMID: 29424320]

Grants

  1. 82060719/National Natural Science Foundation of China

MeSH Term

Humans
Biological Products
Antineoplastic Agents
Neoplasms
Drug Discovery

Chemicals

Biological Products
Antineoplastic Agents
Journal Article Review

Word Cloud

Similar Articles

Cited By